EXCLUSIVE Sanofi offers to buy U.S. biotech, mRNA partner Translate Bio -sources
Sanofi board discussed deal on Sunday U.S. biotech company's shares soar more than 70% after report Financial terms not known PARIS, Aug 2 (Reuters) - Sanofi (SASY.PA) has offered to buy U.S. biotech company Translate Bio (TBIO.O), two sources familiar with the situation said on Monday, as the French drugmaker bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race. Shares in the New York-listed biotech company soared more than 70% to above $50 in extended trading, building on the big gains in the stock as investors have piled in to the sector amid a rush to develo...